Impact of obesity on procedural safety and 1-year outcomes after pulsed-field ablation for atrial fibrillation
35 affiliations
- 1Cardiology Department, CHU Clermont-Ferrand, 58 rue Montalembert, Clermont-Ferrand F-63000, France.
- 2Institut Pascal, Université Clermont Auvergne, CNRS, SIGMA Clermont, 4 avenue Blaise Pascal, TSA 60026 / CS 60026, Aubière Cedex F-63178, France.
- 3Department of Cardiology, Rouen University Hospital and UNIROUEN, INSERM U1096, Rouen, France.
- 4Institut de Cardiologie, Hôpital Pitié-Salpêtrière, AP-HP Sorbonne Université, Paris, France.
- 5Department of Biostatistics, CHU Clermont-Ferrand, Clermont-Ferrand F-63000, France.
- 6Department of Cardiology, GHP Ambroise Paré Hartmann, Neuilly-sur-Seine, France.
- 7Department of Cardiology, Toulouse University Hospital, Toulouse, France.
- 8Cardiology Department, Grenoble-Alpes University, University Hospital, Grenoble, France.
- 9Heart Rhythm Management Department, Clinique Pasteur, Toulouse, France.
- 10Division of Cardiology, European Georges Pompidou Hospital, Paris, France.
- 11Department of Cardiology, Centre Cardiologique du Nord, Saint-Denis, France.
- 12Department of Cardiology, Pôle Santé République, Clermont-Ferrand, France.
- 13Department of Cardiology, Clinique du Millénaire, Montpellier, France.
- 14Cardiology Department, Datacoeur Research Team, ETHICS Laboratory, GHICL Hôpital Saint Philibert, Lille, France.
- 15Cardiac Arrhythmia Department, IHU Liryc, Univ. Bordeaux, INSERM 1045, CHU de Bordeaux, Bordeaux, France.
- 16Department of Cardiology, Caen University Hospital, Caen, France.
- 17Department of Cardiology, CHU de Montpellier, Montpellier, France.
- 18Department of Cardiology, Hôpital de la Croix-Rousse, Lyon, France.
- 19Department of Cardiology, Institut Arnault Tzanck, Saint-Laurent-du-Var, France.
- 20Department of Cardiology, CHU de Tours, Tours, France.
- 21Department of Cardiology, Hôpital Privé du Confluent, Nantes, France.
- 22Department of Cardiology, Polyclinique Saint-Laurent, Rennes, France.
- 23Department of Cardiology, CHU de Saint-Étienne, Saint-Étienne, France.
- 24Department of Cardiology, AP-HP Hôpital Bichat, Paris, France.
- 25Department of Cardiology, Clinique Saint Augustin, Bordeaux, France.
- 26Department of Cardiology, Clinique Saint-Pierre, Perpignan, France.
- 27Department of Cardiology, Polyclinique Reims-Bezannes, Bezannes, France.
- 28Department of Cardiology, Clinique Victor Pauchet, Amiens, France.
- 29Department of Cardiology, Clinique Saint-Joseph, Trélazé, France.
- 30Department of Cardiology, Centre Hospitalier de Pau, Pau, France.
- 31Department of Cardiology, CHU de Marseille, Marseille, France.
- 32Department of Cardiology, CHU de Poitiers, Poitiers, France.
- 33Department of Cardiology, CHU de Limoges, Limoges, France.
- 34Department of Cardiology, CHU de Lille, Lille, France.
- 35Department of Cardiology, University Hospital Nancy, Nancy, France.
Abstract
Aims
Obesity is associated with atrial fibrillation (AF), atrial remodelling, and cardiometabolic comorbidities. Whether baseline body mass index (BMI) influences procedural safety and effectiveness of pulsed-field ablation (PFA) remains uncertain. We evaluated the association of baseline BMI with procedural characteristics, periprocedural safety, and 1-year arrhythmia recurrence after first-time PFA for AF.Methods and results
FRANCE-PFA is a nationwide registry including consecutive patients undergoing first-time AF ablation with a pentaspline PFA catheter. Patients with available BMI were categorized as <25, 25 to <30, 30 to <35, or ≥35 kg/m2. Periprocedural complications and 1-year atrial arrhythmia recurrence were assessed across BMI categories. Among 5223 patients, BMI was available in 4573 (87.6%). Higher BMI was associated with greater cardiometabolic burden, more persistent AF, larger atria, and more extensive ablation strategies, including fewer pulmonary vein isolation-only procedures and more additional lesion sets (all P < 0.001). Periprocedural complications remained infrequent (1.0%), with no significant difference across BMI categories. At 1 year, recurrence was driven mainly by AF type rather than obesity. Within paroxysmal and non-paroxysmal AF, recurrence rates were comparable between patients with BMI < 35 and ≥35 kg/m2 (13.8% vs. 9.1% and 22.9% vs. 23.3%, respectively; log-rank P = 0.925). Severe obesity was not associated with recurrence after multivariable adjustment (HR, 0.86; 95% CI, 0.65-1.14; P = 0.299), with similar findings when BMI was analysed continuously.Conclusion
In this nationwide PFA cohort, higher BMI identified a more advanced AF phenotype and more extensive ablation strategies but was not independently associated with periprocedural complications or 1-year arrhythmia recurrence.
Related
- Impact of obesity on clinical outcomes and the treatment effect of catheter ablation in atrial fibrillation: insights from CABANA
- Sedation and anaesthesia in pulsed-field ablation for atrial fibrillation: mechanisms, procedural requirements, and real-world practice.
- Cardiometabolic Substrate Modification in Atrial Fibrillation: Obesity and Epicardial Adipose Tissue in the Era of Incretin-Based Therapies and Catheter Ablation
- The weight of evidence: does obesity really not matter for atrial fibrillation ablation? Lessons from CABANA.
- Impact of atrial fibrillation catheter ablation o'n tricuspid regurgitation severity: a systematic review and meta-analysis.
BibTeX
@article{massoullie2026impact,
title = {{Impact of obesity on procedural safety and 1-year outcomes after pulsed-field ablation for atrial fibrillation}},
author = {Grégoire Massoullié and Corentin Chaumont and Mikael Laredo and Bruno Pereira and Olivier Thomas and Philippe Maury and Pascal Defaye and Serge Boveda and Eloi Marijon and William Escande and Antoine Roux and Franck Raczka and Yves Guyomar and Pierre Jaïs and Pierre Ollitrault and Mathieu Granier and Samir Fareh and Hugo Marchand and Bertrand Pierre and Selim Abbey and Antoine Noel and Antoine Da Costa and Fabrice Extramiana and Olivier Cesari and Laure Champ-Rigot and Ziad Khoueiry and Thibault Villemin and Sarah Traullé and Frédéric Treguer and Hugues Bader and Jean-Claude Deharo and Bruno Degand and Benoît Guy-Moyat and Didier Klug and Estelle Gandjbakhch and Alexandre Zhao and Maxime Beneyto and Sandrine Venier and Stéphane Combes and Antoine Lepillier and Marc Mielczarek and Nicolas Clementy and Aymeric Menet and Frédéric Sacher and Christian De Chillou and Romain Eschalier and Frédéric Anselme and FRANCE-PFA Registry},
journal = {Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology},
year = {2026},
month = oct,
doi = {10.1093/europace/euag288},
url = {https://europepmc.org/article/PMC/PMC13717914},
note = {CC BY},
}
RIS
TY - JOUR
TI - Impact of obesity on procedural safety and 1-year outcomes after pulsed-field ablation for atrial fibrillation
AU - Grégoire Massoullié
AU - Corentin Chaumont
AU - Mikael Laredo
AU - Bruno Pereira
AU - Olivier Thomas
AU - Philippe Maury
AU - Pascal Defaye
AU - Serge Boveda
AU - Eloi Marijon
AU - William Escande
AU - Antoine Roux
AU - Franck Raczka
AU - Yves Guyomar
AU - Pierre Jaïs
AU - Pierre Ollitrault
AU - Mathieu Granier
AU - Samir Fareh
AU - Hugo Marchand
AU - Bertrand Pierre
AU - Selim Abbey
AU - Antoine Noel
AU - Antoine Da Costa
AU - Fabrice Extramiana
AU - Olivier Cesari
AU - Laure Champ-Rigot
AU - Ziad Khoueiry
AU - Thibault Villemin
AU - Sarah Traullé
AU - Frédéric Treguer
AU - Hugues Bader
AU - Jean-Claude Deharo
AU - Bruno Degand
AU - Benoît Guy-Moyat
AU - Didier Klug
AU - Estelle Gandjbakhch
AU - Alexandre Zhao
AU - Maxime Beneyto
AU - Sandrine Venier
AU - Stéphane Combes
AU - Antoine Lepillier
AU - Marc Mielczarek
AU - Nicolas Clementy
AU - Aymeric Menet
AU - Frédéric Sacher
AU - Christian De Chillou
AU - Romain Eschalier
AU - Frédéric Anselme
AU - FRANCE-PFA Registry
PY - 2026
DA - 2026/10/01
JO - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
DO - 10.1093/europace/euag288
UR - https://europepmc.org/article/PMC/PMC13717914
AB - Aims Obesity is associated with atrial fibrillation (AF), atrial remodelling, and cardiometabolic comorbidities. Whether baseline body mass index (BMI) influences procedural safety and effectiveness of pulsed-field ablation (PFA) remains uncertain. We evaluated the association of baseline BMI with procedural characteristics, periprocedural safety, and 1-year arrhythmia recurrence after first-time PFA for AF.Methods and results FRANCE-PFA is a nationwide registry including consecutive patients undergoing first-time AF ablation with a pentaspline PFA catheter. Patients with available BMI were categorized as <25, 25 to <30, 30 to <35, or ≥35 kg/m2. Periprocedural complications and 1-year atrial arrhythmia recurrence were assessed across BMI categories. Among 5223 patients, BMI was available in 4573 (87.6%). Higher BMI was associated with greater cardiometabolic burden, more persistent AF, larger atria, and more extensive ablation strategies, including fewer pulmonary vein isolation-only procedures and more additional lesion sets (all P < 0.001). Periprocedural complications remained infrequent (1.0%), with no significant difference across BMI categories. At 1 year, recurrence was driven mainly by AF type rather than obesity. Within paroxysmal and non-paroxysmal AF, recurrence rates were comparable between patients with BMI < 35 and ≥35 kg/m2 (13.8% vs. 9.1% and 22.9% vs. 23.3%, respectively; log-rank P = 0.925). Severe obesity was not associated with recurrence after multivariable adjustment (HR, 0.86; 95% CI, 0.65-1.14; P = 0.299), with similar findings when BMI was analysed continuously.Conclusion In this nationwide PFA cohort, higher BMI identified a more advanced AF phenotype and more extensive ablation strategies but was not independently associated with periprocedural complications or 1-year arrhythmia recurrence.
SN - 1099-5129
SN - 1532-2092
ER -